z-logo
open-access-imgOpen Access
The current state of drug repurposing and rare diseases: an interview with Paul Trippier
Author(s) -
Paul C. Trippier
Publication year - 2020
Publication title -
future drug discovery
Language(s) - English
Resource type - Journals
ISSN - 2631-3316
DOI - 10.4155/fdd-2019-0037
Subject(s) - repurposing , drug repositioning , editorial board , key (lock) , state (computer science) , library science , drug discovery , drug , medicine , gerontology , pharmacology , engineering , computer science , bioinformatics , biology , computer security , waste management , algorithm
Paul Tripper is an Associate Professor of Medicinal Chemistry at the University of Nebraska Medical Center (UNMC, NE, USA) and an Editorial Board member of Future Drug Discovery. Here, he speaks to Managing Editor Francesca Lake about drug repurposing, focusing on the key challenges, its application to rare diseases and what we can look forward to in the future.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here